| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.37 | 0.03 |